Mitochondrial toxicity assessment in industry – a decade of technology development and insight

Bibliography

• Dimauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med 2005;37:222-32
   PubMed Web of Science ®Google Scholar
• Tirmenstein MA, Hu CX, Gales TL, et al. Effects of troglitazone on HepG2 viability and mitochondrial function. Toxicol Sci 2002;69:131-8
   PubMed Web of Science ®Google Scholar
• Westwood FR, Bigley A, Randall K, et al. Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol Pathol 2005;33:246-57
   PubMed Web of Science ®Google Scholar
• Dykens JA, Marroquin LD, Will Y. Strategies to reduce late-stage drug attrition due to mitochondrial toxicity. Expert Rev Mol Diagn 2007;7:161-75
   PubMed Web of Science ®Google Scholar
• Website describing oxygraphs. Available from: www.hansatech.com [Last accessed 20 June 2014]
   Google Scholar
• Website describing high resolution respirometry. Available from: www.orosboros.com [Last accessed 20 June 2014]
   Google Scholar
• Website desribign soluble oxygen sensors. Available from: www.luxcel.com [Last accessed 20 June 2014]
   Google Scholar
• Hynes J, Marroquin LD, Ogurtsov VI, et al. Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes. Toxicol Sci 2006;92:186-200
   PubMed Web of Science ®Google Scholar
• Hynes J, Natoli E Jr, Will Y. Fluorescent pH and oxygen probes of the assessment of mitochondrial toxicity in isolated mitochondria and whole cells. Curr Protoc Toxicol 2009; Chapter 2:Unit 2.16
   PubMedGoogle Scholar
• Hynes J, Swiss RL, Will Y. High-throughput analysis of mitochondrial oxygen consumption. Methods Mol Biol 2012;810:59-72
   PubMedGoogle Scholar
• Nadanaciva S, Bernal A, Aggeler R, et al. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol In Vitro 2007;21:902-11
   PubMed Web of Science ®Google Scholar
• Nadanaciva S, Dykens JA, Bernal A, et al. Mitochondrial toxicity of PPAR agonists and statins is exacerbated by combined exposure. Toxicol Appl Pharmacol 2007;223:277-87
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999;343:281-99
   PubMed Web of Science ®Google Scholar
• Wang DS, Kusuhara H, Kato Y, et al. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003;63:844-8
   PubMed Web of Science ®Google Scholar
• Dykens JA, Jamieson J, Marroquin L, et al. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol 2008;233:203-10
   PubMed Web of Science ®Google Scholar
• Dykens JA, Jamieson JD, Marroquin LD, et al. In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicol Sci 2008;103:335-45
   PubMed Web of Science ®Google Scholar
• Marroquin LD, Hynes J, Dykens JA, et al. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 2007;97:539-47
   PubMed Web of Science ®Google Scholar
• Swiss R, Will Y. Assessment of mitochondrial toxicity in HepG2 cells cultured in high-glucose- or galactose-containing media. Curr Protoc Toxicol 2011; Chapter 2:Unit2.20
   PubMedGoogle Scholar
• Reitzer LJ, Wice BM, Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 1979;254:2669-76
   PubMed Web of Science ®Google Scholar
• Hynes J, Nadanaciva S, Swiss R, et al. A high-throughput dual parameter assay for assessing drug-induced mitochondrial dysfunction provides additional predictivity over two established mitochondrial toxicity assays. Toxicol In Vitro 2013;27:560-9
   PubMed Web of Science ®Google Scholar
• Swiss R, Niles A, Cali JJ, et al. Validation of a HTS-amenable assay to detect drug-induced mitochondrial toxicity in the absence and presence of cell death. Toxicol In Vitro 2013;27:1789-97
   PubMed Web of Science ®Google Scholar
• Website describing the mitochondrial toxicity test. Available from: www.promega.com [Last accessed 20 June 2014]
   Google Scholar
• Website describing the metablic flux analyzer. Available from: www.seahorsebiosciences.com [Last accessed 20 June 2014]
   Google Scholar
• Nadanaciva S, Rana P, Beeson GC, et al. Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform. J Bioenerg Biomembr 2012;44:421-37
   PubMed Web of Science ®Google Scholar
• Porceddu M, Buron N, Roussel C, et al. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol Sci 2012;129:332-45
   PubMed Web of Science ®Google Scholar
• Aleo MD, Luo Y, Swiss R, et al. Human drug-induced liver injury severity is highly associated to dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology 2014; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Ong MM, Latchoumycandane C, Boelsterli UA. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Toxicol Sci 2007;97:205-13
   PubMed Web of Science ®Google Scholar
• Hsiao CJ, Younis H, Boelsterli UA. Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction. Chem Biol Interact 2010;188:204-13
   PubMed Web of Science ®Google Scholar
• Pereira CV, Oliveira PJ, Will Y, Nadanaciva S. Mitochondrial bioenergetics and drug-induced toxicity in a panel of mouse embryonic fibroblasts with mitochondrial DNA single nucleotide polymorphisms. Toxicol Appl Pharmacol 2012;264:167-81
   PubMed Web of Science ®Google Scholar
• Amara CE, Marcinek DJ, Shankland EG, et al. Mitochondrial function in vivo: spectroscopy provides window on cellular energetics. Methods 2008;46:312-18
   PubMed Web of Science ®Google Scholar
• Website describing antibodies commonly used for mitochondrial research. Available from: www.mitosciences.com [Last accessed 20 June 2014]
   Google Scholar
• Naven RT, Swiss R, Klug-McLeod J, et al. The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation. Toxicol Sci 2013;131:271-8
   PubMed Web of Science ®Google Scholar
• Nadanaciva S, Dillman K, Gebhard DF, et al. High-content screening for compounds that affect mtDNA-encoded protein levels in eukaryotic cells. J Biomol Screen 2010;15:937-48
   PubMed Web of Science ®Google Scholar
• Laifenfeld D, Qiu L, Swiss R, et al. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Toxicol Sci 2014;137:234-48
   PubMed Web of Science ®Google Scholar
• McGill MR, Jaeschke H. Apoptosis or necrosis in acetaminophen-induced acute liver failure? New insights from mechanistic biomarkers. Crit Care Med 2013;41:2653-4
   PubMed Web of Science ®Google Scholar
• McGill MR, Cao M, Svetlov A, et al. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 2014;19:222-30
   PubMed Web of Science ®Google Scholar
• Korrapati M, Whitaker RM, Stallons LJ, et al. ATP synthase beta is a novel urinary biomarker of renal mitochondrial dysfunction. Toxicologist 2014;138:25
   Google Scholar
• Stallons LJ, Arthur J, Beeson C, Schnellmann RG. Urinary mitochondrial DNA as a novel biomarker of mitochondrial dysfunction in human acute kidney injury. Toxicologist 2014;138:24
   Google Scholar
• Website of global provider of genetically modified mouse and rat models and services. Available from: www.taconic.com [Last accessed 25 June 2014]
   Google Scholar